TABLE 3.
Laboratory results at diagnosis
| Variable | Asthmatic | Control | p-value | ||
| Data | Patients# n | Data | Patients# n | ||
| Leukocytes cells·mm−3 | 6990 (5710–9020) | 37 | 6690 (5330–9483) | 74 | 0.719 |
| Haemoglobin g·dL−1 | 13.0 (12.3–14.7) | 37 | 13.5 (12.6–14.6) | 74 | 0.819 |
| Platelets cells·mm−3 | 213 000 (159 000–239 000) | 37 | 206 000 (165 000–254 000) | 74 | 0.699 |
| Neutrophils cells·mm−3 | 5225 (2835–6910) | 36 | 5160 (3815–7698) | 74 | 0.883 |
| Eosinophils cells·mm−3 | 0 (0–0) | 36 | 0 (0–0) | 74 | 0.254 |
| Lymphocytes cells·mm−3 | 1205 (738–1475) | 36 | 890 (623–1308) | 74 | 0.151 |
| Fibrinogen g·L−1 | 5.2 (4.2–6.2) | 35 | 6.1 (5.1–7.2) | 73 | 0.002* |
| D-dimers μg·L−1 | 810 (483–1180) | 34 | 1080 (680–1508) | 64 | 0.329 |
| CRP mg·L−1 | 51 (27–116) | 37 | 86 (51–174) | 75 | 0.040* |
| LDH IU·L−1 | 283 (235–359) | 31 | 392 (311–512) | 66 | 0.005* |
| CPK IU·L−1 | 100 (62–160) | 33 | 189 (84–390) | 71 | 0.245 |
| ASAT IU·L−1 | 38 (25–62) | 33 | 51 (39–73) | 69 | 0.022* |
| ALAT IU·L−1 | 30 (23–47) | 34 | 37 (27–64) | 71 | 0.058 |
| Bilirubin mg·L−1 | 6 (4–8) | 34 | 9 (6–13) | 71 | 0.157 |
| Troponin T HS ng·L−1 | 6 (4–13) | 31 | 12 (8–21) | 63 | 0.119 |
| NT-proBNP ng·L−1 | 131 (52–214) | 21 | 230 (54–1713) | 44 | 0.745 |
| Ferritin ng·mL−1 | 632 (460–985) | 8 | 1626 (903–3031) | 15 | 0.034* |
| PaO2 in room air mmHg | 68 (62–83) | 29 | 63 (52–74) | 61 | 0.010* |
| PaCO2 in room air mmHg | 34 (32–38) | 29 | 35 (32–38) | 61 | 0.762 |
Data are presented as median (interquartile range), unless otherwise stated. The interquartile range is presented as first quartile – third quartile. CRP: C-reactive protein; LDH: lactate dehydrogenase; CPK: creatine phosphokinase; ASAT: aspartate transaminase; ALAT: alanine aminotransferase; troponin T HS: high-sensitive cardiac troponin T; NT-proBNP: N-terminal pro-brain natriuretic peptide; PaO2: arterial oxygen tension; PaCO2: arterial carbon dioxide tension. #: patients with available information. *: p<0.05.